First Light Asset Management LLC Has $17.34 Million Stock Position in KORU Medical Systems, Inc. $KRMD

First Light Asset Management LLC lowered its position in shares of KORU Medical Systems, Inc. (NASDAQ:KRMD) by 3.3% in the third quarter, HoldingsChannel reports. The fund owned 4,527,737 shares of the company’s stock after selling 153,889 shares during the period. KORU Medical Systems accounts for approximately 1.6% of First Light Asset Management LLC’s investment portfolio, making the stock its 23rd largest holding. First Light Asset Management LLC owned approximately 0.10% of KORU Medical Systems worth $17,341,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in KRMD. Police & Firemen s Retirement System of New Jersey bought a new position in KORU Medical Systems in the second quarter valued at about $30,000. BNP Paribas Financial Markets raised its holdings in KORU Medical Systems by 52.1% during the 3rd quarter. BNP Paribas Financial Markets now owns 10,148 shares of the company’s stock worth $39,000 after purchasing an additional 3,478 shares during the last quarter. Lazard Asset Management LLC acquired a new position in KORU Medical Systems during the 2nd quarter valued at about $59,000. Acadian Asset Management LLC acquired a new position in KORU Medical Systems during the 1st quarter valued at about $63,000. Finally, Intech Investment Management LLC bought a new position in shares of KORU Medical Systems in the 2nd quarter valued at about $73,000. Institutional investors and hedge funds own 58.60% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently commented on KRMD shares. Lake Street Capital lifted their price target on shares of KORU Medical Systems from $6.00 to $8.00 and gave the stock a “buy” rating in a research report on Monday, December 22nd. Craig Hallum restated a “buy” rating and issued a $7.00 price objective on shares of KORU Medical Systems in a report on Tuesday, January 13th. B. Riley Financial raised their price objective on shares of KORU Medical Systems from $7.00 to $8.00 and gave the company a “buy” rating in a research note on Friday. Canaccord Genuity Group reaffirmed a “buy” rating and set a $6.00 target price on shares of KORU Medical Systems in a report on Friday. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of KORU Medical Systems in a research report on Thursday, January 22nd. Four equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, KORU Medical Systems currently has an average rating of “Moderate Buy” and a consensus target price of $6.50.

Key Stories Impacting KORU Medical Systems

Here are the key news stories impacting KORU Medical Systems this week:

• Positive Sentiment: B. Riley raised its price target to $8.00 and maintained a “buy” rating, implying roughly an 87% upside from the current price — a meaningful vote of confidence from a major dealer. Benzinga
• Positive Sentiment: Canaccord Genuity reaffirmed its “buy” rating and set a $6.00 target (≈40% upside), adding further analyst support for upside to the stock. Benzinga
• Positive Sentiment: KORU received EU MDR certification for its Freedom60® infusion pump with prefilled syringe compatibility — clear regulatory progress that should aid European commercialization and recurring revenue potential. Las Vegas Sun
• Positive Sentiment: Q4 2025 results beat EPS expectations (loss of $0.01 vs. -$0.02 est.), reported ~20% revenue growth and positive adjusted EBITDA; management also initiated FY2026 guidance with revenue of $47.5M–$50.0M (roughly in line with consensus ~ $48.8M). These operational improvements support medium-term growth prospects. Business Wire – Q4 & Guidance
• Neutral Sentiment: Analysts and the company provided forward revenue guidance but EPS guidance detail was not clearly disclosed in public summaries; revenue range is encouraging but leaves some near-term visibility questions. Q4 Press Release / Slide Deck
• Negative Sentiment: KORU announced a CEO transition: long-time CEO Linda Tharby will retire June 30 and the board appointed Adam Kalberma as successor. Leadership changes introduce short-term execution risk and can pressure the stock until the market judges the new CEO. Business Wire – CEO Transition
• Negative Sentiment: Despite positives, KRMD still shows a negative net margin and negative ROE; valuation and profitability concerns may keep selling pressure, which likely explains why the stock is trading lower even after upgrades and regulatory wins.

KORU Medical Systems Stock Performance

NASDAQ KRMD opened at $4.28 on Monday. The stock has a market cap of $198.46 million, a price-to-earnings ratio of -71.33 and a beta of 0.47. The business has a 50 day simple moving average of $5.10 and a 200 day simple moving average of $4.80. KORU Medical Systems, Inc. has a 52-week low of $1.86 and a 52-week high of $6.61.

KORU Medical Systems (NASDAQ:KRMD) last announced its quarterly earnings results on Thursday, March 12th. The company reported ($0.01) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.01. The firm had revenue of $10.90 million for the quarter, compared to analyst estimates of $10.90 million. KORU Medical Systems had a negative net margin of 6.41% and a negative return on equity of 15.90%. On average, analysts predict that KORU Medical Systems, Inc. will post -0.13 EPS for the current year.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products.